The future of DMTs in Neurology looks promising with ongoing research aimed at developing more effective and safer treatments. Advances in personalized medicine and genetic therapies hold the potential to tailor treatments to individual patients' genetic profiles, thereby enhancing efficacy and minimizing risks. Furthermore, the exploration of new targets and mechanisms of action continues to expand the therapeutic arsenal against neurological diseases.
